Paul A. Krogstad, MD
Accepting new patients

Paul A. Krogstad, MD


Clinical Expertise:

Enterovirus infections, HIV therapy, bone and joint infections, viral myocarditis


Dr. Paul Krogstad attended UCLA and received his Bachelor of Science in Cybernetics and a Master's Degree in Engineering. After leaving Los Angeles, he attended the Tulane University School of Medicine in New Orleans, Louisiana, where he also completed his training in Pediatrics.

He trained as a specialist in Pediatric Infectious Diseases at the University of Washington in Seattle, then returned to UCLA for additional postdoctoral training in human retrovirology. He joined the UCLA faculty in 1992 and is now a Professor in the departments of Pediatrics and Pharmacology.

Dr. Krogstad's research has largely focused on molecular virology and the pathogenesis of viral diseases. His studies currently include evaluation of new treatments for HIV infected children and adolescents and the discovery of antiviral agents for enterovirus infections. In addition, he has collaborated with others in the study of Valley Fever (Coccidioidomycosis).

Memberships, Major Committees

Member, Department of Health and Human Services (HHS) Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children, 2007 - present

Service to Hospital, Medical School, and UCLA AIDS Institute.

Member, Antimicrobial Agent Subcommittee of the UCLA Pharmacy and Therapeutics

Department of Pediatrics
Chair, Departmental Review and Appraisal Committee




Medical Board Certifications

Pediatric Infectious Diseases, American Board of Pediatrics, 1994
Pediatrics, American Board of Pediatrics, 1989


Retrovirology, UCLA School of Medicine, 1992
Pediatrics/Infectious Diseases, University of Washington Medical Center, 1990


Pediatrics, Tulane University Hospital & Clinics, 1987


Pediatrics, Tulane University Hospital & Clinics, 1985


MD, Tulane University School of Medicine, 1984


  • Top Doctors, Los Angeles Magazine, 2022
  • Top Doctors, Los Angeles Magazine, 2021
  • Top Doctors, Los Angeles Magazine, 2018
  • See More

Hospital Affiliations


Vaccines: Separating Myth from Reality



HIV therapy and immunopathogenesis
Enterovirus disease and its treatment
Genetic basis for disseminated coccidioidomycosis


Selected Publications:

Link to my PubMed publications >

  1. Rudy BJ, Kapogiannis BG, Lally MA, Gray GE, Bekker LG, Krogstad P, and McGowan I. Youth Specific Considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials.J. Acquir Immune Syndr 2010;54:S31-S42.
  2. Kitchen CMR, Krogstad Pand Kitchen SG. In Vivo Validation of a Bioinformatics Based Tool to Identify Reduced Replication Capacity in HIV. The Open Medical Informatics Journal 2010; 225-232.
  3. Zuo J, Church J, Belzer M, Kitchen CR, Ank B, Schmid I, and Krogstad P. Enhanced CD8+ T Cell Apoptosis in HIV Infected Adolescents. AIDS Res Hum Retro 2010; 26:681-4.
  4. Wolf MC, Freiberg AN, Zhang T, Akyol-Ataman Z, Li J, Hong PW, Aguilar HC, Grock A, Honko AN, Johnson J, Porotto M, Damoiseaux R, Miller JP, Negrete OA, Krogstad P, Moscona A, Hensley LE, Whelan SP, Holbrook MR, Jung ME, Lee B. A novel, potent broad-spectrum antiviral targeting enveloped virus entry. Proc Natl Acad Sci. 2010;107:3157- 62.
  5. Reiff A, Krogstad P, Moore S, Shaham B, Parkman R, Kitchen C, and Weinberg K. Study of Thymic Size and Function in Children and Adolescents with Treatment Refractory Systemic Sclerosis Eligible for Immunoablative Therapy. Clinical Immunology 2009;133:295-302
  6. Miller JP, Geng YZ, NG W, Yang OO, and Krogstad P. Packaging Limits and Stability of HIV-1 Sequences in a Coxsackievirus B Vector. Vaccine 2009; 27: 3992-4000.
  7. Jhaveri R, Bronstein D, Sollod J, Kitchen CR, and Krogstad P. Outcome of Infections with Extended Spectrum Beta-Lactamase Producing Organisms in Children. J Pediatric Infectious Diseases. 2008; 3: 229-233
  8. Krogstad P, Hammon R, Halnon NJ, and Whitton JL. Fatal Neonatal Myocarditis Caused by a Recombinant Human Enterovirus-B Variant. Ped Inf. Dis J. 2008;27:668-9.
  9. Kitchen CMR, Nuño M, Kitchen SG, and Krogstad PA. Enfuvirtide antiretroviral therapy in HIV-1 infection. Ther Clin Risk Manag. 2008; 4:433-9.
  10. Lee JC, Boechat MI, Belzer M, Church JA, De Ville J, Nielsen K, Weston S, Geng Y, Dunaway T, Kitchen C, and Krogstad PA. Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy. AIDS. 2006;20:667-74.


  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.


  • Top Doctors, Los Angeles Magazine, 2022
  • Top Doctors, Los Angeles Magazine, 2021
  • Top Doctors, Los Angeles Magazine, 2018
  • Tulane University nomination: AOA honor society
  • Pediatric AIDS Foundation Scholar Award
  • Robert C. Neerhout Teaching Award
  • Elizabeth Glaser Pediatric AIDS Foundation Scientist Award